Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD

Abstract

Baseline blood eosinophil levels may represent an informative marker for exacerbation reduction with ICS/LABA in patients with COPD and a history of moderate/severe exacerbations.